PenderFund Capital Management’s Acceleron Pharma XLRN Stock Holding History

PenderFund Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$44K	–	175
2021 Q3	$44K	Buy	+200	New	+$26.2K	0.01%	68

PenderFund Capital Management's XLRN Position: Q4 2021 in Review

PenderFund Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 200 shares — an estimated $44K sold.

PenderFund Capital Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $44K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

PenderFund Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
PenderFund Capital Management sold 200 Acceleron Pharma shares in Q4 2021, an estimated $44K.
PenderFund Capital Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
PenderFund Capital Management's Acceleron Pharma position peaked at $44K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on PenderFund Capital Management's 13F filing for Q4 2021, filed 16 Feb 2022.